Evidence map›Paper›PMID 38480979›Full record

ArticleCommunications biology2024

Classification of likely functional class for ligand binding sites identified from fragment screening.

Javier S Utgés, Stuart A MacGowan, Callum M Ives, Geoffrey J Barton

Open access · goldAbstract read
In one paragraph

Article in Communications biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Javier S UtgésDivision of Computational Biology, School of Life Sciences, University of Dundee, Dundee, Scotland, UK.ORCID 0000-0002-1078-1440
Stuart A MacGowanDivision of Computational Biology, School of Life Sciences, University of Dundee, Dundee, Scotland, UK.ORCID 0000-0003-4233-5071
Callum M IvesDivision of Computational Biology, School of Life Sciences, University of Dundee, Dundee, Scotland, UK.ORCID 0000-0003-0511-1220
Geoffrey J BartonDivision of Computational Biology, School of Life Sciences, University of Dundee, Dundee, Scotland, UK. gjbarton@dundee.ac.uk.ORCID 0000-0002-9014-5355
University of Dundee · GBNational University of Ireland, Maynooth · IE

Funding

RCUK | Biotechnology and Biological Sciences Research Council (BBSRC) BB/J01446X/1RCUK | Biotechnology and Biological Sciences Research Council (BBSRC) BB/J019364/1RCUK | Biotechnology and Biological Sciences Research Council (BBSRC) BB/R014752/1Wellcome TrustWellcome Trust (Wellcome) 101651/Z/13/ZWellcome Trust (Wellcome) 218259/Z/19/Z
6 · The paper itself

Abstract

Fragment screening is used to identify binding sites and leads in drug discovery, but it is often unclear which binding sites are functionally important. Here, data from 37 experiments, and 1309 protein structures binding to 1601 ligands were analysed. A method to group ligands by binding sites is introduced and sites clustered according to profiles of relative solvent accessibility. This identified 293 unique ligand binding sites, grouped into four clusters (C1-4). C1 includes larger, buried, conserved, and population missense-depleted sites, enriched in known functional sites. C4 comprises smaller, accessible, divergent, missense-enriched sites, depleted in functional sites. A site in C1 is 28 times more likely to be functional than one in C4. Seventeen sites, which to the best of our knowledge are novel, in 13 proteins are identified as likely to be functionally important with examples from human tenascin and 5-aminolevulinate synthase highlighted. A multi-layer perceptron, and K-nearest neighbours model are presented to predict cluster labels for ligand binding sites with an accuracy of 96% and 100%, respectively, so allowing functional classification of sites for proteins not in this set. Our findings will be of interest to those studying protein-ligand interactions and developing new drugs or function modulators.

Indexed as

Drug DiscoveryProteinsBinding SitesHumansLigandsLigandsProteins

Identifiers

PMID38480979
PMCPMC10937669
OpenAlexW4392746709

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.